These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3609636)

  • 1. [Protection of medical innovations].
    Sezeur A; Tarragano O
    Gastroenterol Clin Biol; 1987 May; 11(5):418-20. PubMed ID: 3609636
    [No Abstract]   [Full Text] [Related]  

  • 2. [Valuation of innovation: a new challenge for the structures of care, an opportunity for everybody...].
    Sezeur A
    J Mal Vasc; 2010 Feb; 35(1):1-3. PubMed ID: 20042305
    [No Abstract]   [Full Text] [Related]  

  • 3. [Patents and innovations. Definitions--modes of action].
    Lodde JP
    Ann Chir Plast Esthet; 1994 Jun; 38(3):343-5; discussion 346. PubMed ID: 8210201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical innovation. Patents and confidentiality].
    Laccourreye O; Sezeur A; Cauchois R; Rodhain C
    Ann Otolaryngol Chir Cervicofac; 1993; 110(3):173-6. PubMed ID: 8239339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Self-interest can be of benefit for everyone and save medical research].
    Fändriks L; Edén S
    Lakartidningen; 2001 Jun; 98(26-27):3146-9. PubMed ID: 11478213
    [No Abstract]   [Full Text] [Related]  

  • 6. Much ado about gene patents: the role of foreseeability.
    Gulliford MJ
    Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
    [No Abstract]   [Full Text] [Related]  

  • 7. Patenting of pure surgical and other medical procedures. Medical community's response and need for a legislative solution.
    Coble YD; Ile M; Taylor MB
    J Fla Med Assoc; 1996 May; 83(5):329-31. PubMed ID: 8666970
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of patent term restoration to pharmaceutical innovation.
    Huntt PB
    Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 10324213
    [No Abstract]   [Full Text] [Related]  

  • 9. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent pending. The challenges of bringing an invention to market.
    Goldman PM
    Minn Med; 1999 Sep; 82(9):29-31. PubMed ID: 10510615
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishing novelty and relevant prior art.
    Murphy C
    Nat Rev Drug Discov; 2004 Jul; 3(7):545. PubMed ID: 15272495
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene patent policy: does issuing gene patents accord with the purposes of the U.S. patent system?
    Bradshaw J
    Willamette Law Rev; 2001; 37(4):637-60. PubMed ID: 12774776
    [No Abstract]   [Full Text] [Related]  

  • 13. [Directives from the commander of the Main Military Medical Administration of the Ministry of Defense of the Russian Federation].
    Voen Med Zh; 2000 Jan; 321(1):108-9. PubMed ID: 10744553
    [No Abstract]   [Full Text] [Related]  

  • 14. What's holding us back? Understanding barriers to innovation in academic neurosurgery.
    Leuthardt EC
    Surg Neurol; 2006 Oct; 66(4):347-9; discussion 349. PubMed ID: 17015102
    [No Abstract]   [Full Text] [Related]  

  • 15. ACOG Committee Opinion. Number 364 May 2007. Patents, medicine, and the interests of patients.
    Committees on Ethics and Genetics of American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2007 May; 109(5):1249-54. PubMed ID: 17470613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrary to first impression, genes are patentable: should there be limitations?
    Pitcher AS
    J Health Care Law Policy; 2003; 6(2):284-303. PubMed ID: 15017959
    [No Abstract]   [Full Text] [Related]  

  • 17. Compulsory licensing to regulated licensing: effects on the conflict between innovation and access in the pharmaceutical industry.
    Gillat A
    Food Drug Law J; 2003; 58(4):711-40. PubMed ID: 15027457
    [No Abstract]   [Full Text] [Related]  

  • 18. Clearing a path through the patent thicket.
    Holman C
    Cell; 2006 May; 125(4):629-33. PubMed ID: 16713553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From intellectual property to commercial property].
    Cappelaere P
    Bull Cancer; 2005 Apr; 92(4):297-8. PubMed ID: 15888384
    [No Abstract]   [Full Text] [Related]  

  • 20. Discussions in Geneva, demonstrations in Delhi: why incentives for drug innovation need reviewing.
    Ford N; 't Hoen E; von Schoen-Angerer T
    Drug Discov Today; 2007 May; 12(9-10):349-51. PubMed ID: 17467570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.